High taurine and saturated fat diet for Colorectal Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Rush University Medical Center and University of Illinois at Chicago, Chicago, ILColorectal CancerHigh taurine and saturated fat diet - Other
Eligibility
45 - 75
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study how taurocholic acid metabolism by gut bacteria affects African American subjects' risk for colorectal cancer.

Eligible Conditions
  • Colorectal Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: Baseline and post-diet (day 22) for each of the two 3-week diets

Day 22
Change in DNA damage
Change in bile acid metabolism
Change in colonic mucosal inflammation
Change in colonocyte proliferation
Change in serum bile acids
Change in the mucosal abundance of bacterial genes associated with sulfur and bile acid metabolism

Trial Safety

Trial Design

2 Treatment Groups

High taurine and saturated fat diet
1 of 2
Low in taurine and saturated fat diet
1 of 2

Experimental Treatment

44 Total Participants · 2 Treatment Groups

Primary Treatment: High taurine and saturated fat diet · No Placebo Group · N/A

High taurine and saturated fat diet
Other
Experimental Group · 1 Intervention: High taurine and saturated fat diet · Intervention Types: Other
Low in taurine and saturated fat diet
Other
Experimental Group · 1 Intervention: Low in taurine and saturated fat diet · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline and post-diet (day 22) for each of the two 3-week diets

Who is running the clinical trial?

Rush University Medical CenterOTHER
391 Previous Clinical Trials
153,593 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,154 Previous Clinical Trials
41,163,495 Total Patients Enrolled
University of Illinois at ChicagoLead Sponsor
546 Previous Clinical Trials
1,552,550 Total Patients Enrolled
Lisa Tussing-Humphreys, PhD, MS, RDPrincipal Investigator - University of Illinois at Chicago
University of Illinois at Chicago
2 Previous Clinical Trials
272 Total Patients Enrolled
Ece Mutlu, MD, MS, MBAPrincipal InvestigatorRush University Medical Center
H. Rex Gaskins, PhDPrincipal InvestigatorUniversity of Illinois at Urbana-Champaign
Jason Ridlon, PhDPrincipal InvestigatorUniversity of Illinois at Urbana-Champaign

Eligibility Criteria

Age 45 - 75 · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Only African American adults are eligible for this study.
You have a body mass index (BMI) of 30 or higher, which is considered obese.

Who else is applying?

What state do they live in?
Illinois100.0%
How old are they?
18 - 65100.0%
What site did they apply to?
Rush University Medical Center and University of Illinois at Chicago100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%

How responsive is this trial?

Typically responds via
Phone Call100.0%
Average response time
  • < 2 Days
Most responsive sites:
  1. Rush University Medical Center and University of Illinois at Chicago: < 48 hours

Frequently Asked Questions

Are elderly citizens being included in this research?

"The age range for this particular clinical trial is 45 to 75 years old. In contrast, there are 34 trials involving patients below 18 and 808 trials centering around those over 65." - Anonymous Online Contributor

Unverified Answer

Are new participants still being accepted for this research project?

"That is accurate. The clinical trial detailed on clinicaltrials.gov has open recruitment and was first posted on 8/1/2018. As of the most recent update on 8/22/2022, the study is looking for 44 participants from 1 site." - Anonymous Online Contributor

Unverified Answer

What are the prerequisites for joining this clinical trial?

"The aim of this clinical study is to enroll 44 African American patients with colorectal carcinoma who meet the following conditions: aged 45-75, have an elevated C-reactive protein, are obese, have an increased risk for CRC as defined by having 3 or more adenomatous polyps or 1 adenomatous polyp larger than 1 cm in the last 5 years, be in good general health without any major lifestyle changes planned in the next 6 months, and finally be willing to maintain their current activity level. This trial is only open to post-menopausal women." - Anonymous Online Contributor

Unverified Answer

How many people are enrolled in this research project?

"That is right, the listing on clinicaltrials.gov specifies that this research is recruiting patients as we speak. This trial was initially posted on 8/1/2018 and was last updated on 8/22/2022. The team conducting the study needs to enroll 44 individuals from 1 location." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.